Related Experiment Video
Updated: Apr 27, 2026
05:44
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
4.5K
Pancreatic biomarkers: could they be the answer?
1Angela Lamarca, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.
World Journal of Gastroenterology
|July 1, 2014
Summary
Pancreatic ductal adenocarcinoma (PDA) has a poor prognosis due to late diagnosis and chemo-resistance. Biomarkers offer hope for earlier detection and personalized treatment strategies to improve patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Research
Background:
- Pancreatic ductal adenocarcinoma (PDA) is characterized by a poor prognosis and limited treatment options at advanced stages.
- Delayed diagnosis and intrinsic chemo-resistance contribute to the challenges in improving patient survival rates for PDA.
- Recent advances in understanding PDA's molecular biology offer potential for developing novel diagnostic and therapeutic strategies.
Purpose of the Study:
- To review the current knowledge on the molecular biology of pancreatic ductal adenocarcinoma (PDA).
- To summarize the status of key prognostic and predictive biomarkers for PDA.
- To highlight the potential of biomarkers in improving early detection and treatment individualization for PDA.
Main Methods:
- Comprehensive literature review of recent research on pancreatic ductal adenocarcinoma (PDA) molecular biology.
- Analysis of studies focusing on diagnostic, prognostic, and predictive biomarkers for PDA.
- Synthesis of current findings to assess the clinical utility of identified biomarkers.
Main Results:
- Molecular biology insights have significantly advanced, revealing targets for biomarker development in PDA.
- Several diagnostic, prognostic, and predictive biomarkers show promise for clinical application in PDA.
- Biomarkers are crucial for developing earlier detection methods and tailoring treatment approaches for PDA patients.
Conclusions:
- Biomarkers are essential for improving the clinical outcomes of pancreatic ductal adenocarcinoma (PDA).
- Further research and validation of biomarkers are needed for earlier PDA detection and personalized treatment.
- Leveraging molecular insights and biomarkers is key to overcoming current challenges in PDA management.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
1.6K
14:39A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice
Published on: January 9, 2026
1.1K
Related Concept Videos
01:25Chronic Pancreatitis I: Introduction
25
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
25
01:24Chronic Pancreatitis I: Introduction
903
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
903
01:21Acute Pancreatitis II: Pathophysiology
40
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
40
01:25Acute Pancreatitis I: Introduction
19
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
19
01:29Chronic Pancreatitis II: Collaborative Care
561
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
561
01:26Pancreatic Juice and Secretion
3.4K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.4K